about
ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2.Antigen receptor-mediated depletion of FOXP3 in induced regulatory T-lymphocytes via PTPN2 and FOXO1.Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation.Lymphocyte signaling: regulation of FoxO transcription factors by microRNAs.miR-148a is upregulated by Twist1 and T-bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim.Maintenance of CD8(+) memory T lymphocytes in the spleen but not in the bone marrow is dependent on proliferation.Nuclear factor of activated T cells regulates the expression of interleukin-4 in Th2 cells in an all-or-none fashion.The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells.Free microRNA levels in plasma distinguish T-cell mediated rejection from stable graft function after kidney transplantation.Identification of T Cell-Mediated Vascular Rejection After Kidney Transplantation by the Combined Measurement of 5 Specific MicroRNAs in Blood.Role of Blimp-1 in programing Th effector cells into IL-10 producersAmplifying the fluorescence of bilirubin enables the real-time detection of heme oxygenase activity.Direct uptake of Antagomirs and efficient knockdown of miRNA in primary B and T lymphocytes.Effects of the new immunosuppressive agent AEB071 on human immune cells.Combined standard and novel immunosuppressive substances affect B-lymphocyte function.Selective targeting of pro-inflammatory Th1 cells by microRNA-148a-specific antagomirs in vivo.Effects of sotrastaurin, mycophenolic acid and everolimus on human B-lymphocyte function and activation.The role of the miR-148/-152 family in physiology and disease.Nonfollicular reactivation of bone marrow resident memory CD4 T cells in immune clusters of the bone marrow.IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells.Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function.Conversion to Belatacept based regimen does not change T-cell phenotype and function in renal transplantation.[CRISPR-Cas system as molecular scissors for gene therapy].Stable lines and clones of long-term proliferating normal, genetically unmodified murine common lymphoid progenitors.Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.[Role of non-coding regulatory ribonucleic acids in chronic inflammatory diseases].T-bet expression by Th cells promotes type 1 inflammation but is dispensable for colitis.The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes.miR-148a promotes plasma cell differentiation and targets the germinal center transcription factors Mitf and Bach2.Chromosomal localisation of the CD4cre transgene in B6·Cg-Tg(Cd4-cre)1Cwi mice.The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney TransplantationMicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejectionMicroRNA-31 Reduces the Motility of Proinflammatory T Helper 1 LymphocytesKIR/HLA ligand incompatibility in kidney transplantationQuantification of donor-derived DNA in serum: a new approach of acute rejection diagnosis in a rat kidney transplantation model[MicroRNAs in B-cells and T-cells as regulators of inflammation][Depletion of pro-inflammatory T helper type 1 cells by antagomir-mediated inhibition of the microRNA-148a]c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cellsSpecific microbiota enhances intestinal IgA levels by inducing TGF-β in T follicular helper cells of Peyer's patches in miceCorrection: c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells
P50
Q35064898-E1E535FE-EEA1-4DB7-B794-805BE9CD3D9BQ36250847-7830C430-FBFF-4C7A-A459-3B71FB88FF64Q37818197-F60F8A08-F70D-461B-949E-1C671D058B8BQ37974991-D144922F-8811-47C5-BCA1-A34EC5AFEFB3Q39865491-78996A6C-894F-4D90-9B0F-576F5BA0BED1Q40090495-0F9CFE7C-F9EF-4F2A-8558-0908FF7C7F82Q40208396-CFB1847E-A986-4DED-ABD9-5798B4E61FBCQ40520225-8D428CA4-B2BA-41BF-A1FA-5C3BCC9A784FQ40529298-97A1EC02-C07F-4D3F-A54E-455B9428C082Q40962985-C2E9D075-D9A2-4674-BA22-92D94AE06344Q41844995-3B04EF4C-08EA-4211-B1DC-5779B38912D9Q42445628-CC0ED656-C375-4550-89B4-A48EDAE17478Q43160963-1951A7F5-142A-4C2B-A73E-57103EE72AC9Q43184415-E9BB7ABA-7F50-41BB-AE58-38EB6E860267Q44788341-63238575-21FB-4ABE-B65B-8A467EDCF144Q47355591-FF307831-F193-463E-AA20-8A7C090C2A98Q47362322-F1D04220-319C-4655-8B03-21F86AA67000Q48111289-200466E1-5683-40BC-B6AA-A47FE552ABF2Q48191416-DBB3B419-ADD8-451A-9A05-3436B7C68A5EQ48708663-289ED08E-E7D0-468D-93D9-81F5B71E4426Q50113825-F7BEF3F2-DF03-42A1-820C-DB174D579CA2Q50701406-51F70402-5F5A-452C-8D04-9963A5EFBCECQ52426754-DE90EBF9-D913-48AD-9AE3-6A7F90905C1DQ52639444-10B8B553-39AA-480A-9389-D278B891297EQ52805676-EBE790CD-4F8F-494D-B069-B63DC2C3C873Q52853076-D9686C4C-2E5E-4B7E-9418-F63E6F47C3CEQ52855961-D2DD819D-1B19-4C17-A61F-3C6C499F72C7Q52901064-C844F1F3-AB59-470E-ABBC-49F187B86315Q53617978-3424FDBA-E19D-4EE3-BBC0-BCB069483883Q54151386-21C5B6DB-9F2E-4C0D-BE11-D2671CF2B539Q57807729-EC1863F5-4A45-48C8-9B79-30C6777B6256Q58787180-39C53096-6CFA-473C-B08D-84FFDF8D19F1Q60046093-05103918-E2DE-4194-BE6E-31A95D78AA7DQ80228070-BE14541A-8B5A-41D6-BFE1-472D9A022C1FQ81610407-EDDE20F4-7A0B-45B1-8019-A53042DE4FE5Q84815173-DC677E39-F737-4155-BBD4-3A1CE2D4F33BQ88886543-889979CC-FA12-46BE-9B75-0A9970526DEEQ89625928-A72AA733-F6DD-40B1-9D45-0A7A4A6CBD5FQ89743334-4CBA76AD-566E-4F90-843B-355C1C29D672Q90184665-D79A8869-9347-4DDA-8004-9C89536A2767
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mir-Farzin Mashreghi
@ast
Mir-Farzin Mashreghi
@en
Mir-Farzin Mashreghi
@es
Mir-Farzin Mashreghi
@nl
Mir-Farzin Mashreghi
@sl
type
label
Mir-Farzin Mashreghi
@ast
Mir-Farzin Mashreghi
@en
Mir-Farzin Mashreghi
@es
Mir-Farzin Mashreghi
@nl
Mir-Farzin Mashreghi
@sl
prefLabel
Mir-Farzin Mashreghi
@ast
Mir-Farzin Mashreghi
@en
Mir-Farzin Mashreghi
@es
Mir-Farzin Mashreghi
@nl
Mir-Farzin Mashreghi
@sl
P106
P1153
8206813000
P2798
P31
P496
0000-0002-8015-6907